Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Encompass Health Corporation
  6. News
  7. Summary
    EHC   US29261A1007

ENCOMPASS HEALTH CORPORATION

(EHC)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
53.82 USD   +1.80%
08/12Mizuho Adjusts Encompass Health's Price Target to $65 from $80, Keeps Buy Rating
MT
08/08Truist Securities Adjusts Encompass Health's Price Target to $65 From $75, Maintains Buy Rating
MT
08/04ENCOMPASS HEALTH CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ENCOMPASS HEALTH CORPORATION : Spin off

07/01/2022 EDT
share with twitter
share with LinkedIn
share with facebook

A spin-Off is applied today to Encompass Health Corporation's stock price.



© Factset 2022
All news about ENCOMPASS HEALTH CORPORATION
08/12Mizuho Adjusts Encompass Health's Price Target to $65 from $80, Keeps Buy Rating
MT
08/08Truist Securities Adjusts Encompass Health's Price Target to $65 From $75, Maintains Bu..
MT
08/04ENCOMPASS HEALTH CORP Management's Discussion and Analysis of Financial Condition and ..
AQ
08/04Raymond James Adjusts Encompass Health's Price Target to $65 From $70, Reiterates Stron..
MT
08/04WALL STREET STOCK EXCHANGE : Still seeing the glass half full
MS
08/04ANALYST RECOMMENDATIONS : Illinois Tool Works, Eaton, Marathon Petroleum, Microchip Techno..
MS
08/03Barclays Lowers Encompass Health's Price Target to $63 From $80, Maintains Overweight R..
MT
08/03Credit Suisse Lowers Encompass Health's PT to $63 from $65.20; Keeps Outperform Rating
MT
08/03Deutsche Bank Adjusts Encompass Health's Price Target to $62 From $80, Maintains Buy Ra..
MT
08/03Altru Rehabilitation Hospital, a 37-bed inpatient rehabilitation hospital, now open in ..
PR
More news
Analyst Recommendations on ENCOMPASS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2022 4 507 M - -
Net income 2022 285 M - -
Net Debt 2022 3 189 M - -
P/E ratio 2022 19,0x
Yield 2022 1,59%
Capitalization 5 370 M 5 370 M -
EV / Sales 2022 1,90x
EV / Sales 2023 1,86x
Nbr of Employees 29 294
Free-Float 85,4%
Chart ENCOMPASS HEALTH CORPORATION
Duration : Period :
Encompass Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENCOMPASS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 53,82 $
Average target price 64,73 $
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Mark J. Tarr President, Chief Executive Officer & Director
Douglas E. Coltharp Chief Financial Officer & Executive Vice President
Elissa Joy Charbonneau Chief Medical Officer
Donald L. Correll Independent Director
John W. Chidsey Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ENCOMPASS HEALTH CORPORATION2.62%5 370
AIER EYE HOSPITAL GROUP CO., LTD.-7.60%31 409
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY32.59%20 114
FRESENIUS SE & CO. KGAA-30.59%14 189
IHH HEALTHCARE-11.58%12 855
BANGKOK DUSIT MEDICAL SERVICES22.83%12 707